Atlas Trials

Efficacy and Safety of RTH258 Versus Aflibercept - Study 1

Clinical trial NCT02307682 · COMPLETED

Trial details

NCT number
NCT02307682
Sponsor
Alcon Research
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
Start date
2014-12-08
Primary completion
2017-04-22
Enrollment
1775

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.